Mavupharma mavupharma.com


Public lists: Cancer Therapeutics (1136)

Mavupharma is a drug discovery and development company that is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

Mavupharma is a drug discovery and development company that is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

Company (Alive / Active)

Phone:

Fax:

5400 Carillon Point
Building 5000 4th Floor
Kirkland, 98003
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mavupharma $20M Nov 29, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mavupharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)